Table 6.
Management and outcome of episodes of bacteremia with HACEK in the cohort
| Management and outcome | IE (n = 27) | Non-IE (n = 91) | Odds ratio (95% CI) | P value |
|---|---|---|---|---|
| TTE performed | 25 (93) | 37 (41) | 18 (4.0–82) | < 0.001 |
| TEE performed | 25 (93) | 33 (36) | 22 (4.9–99) | < 0.001 |
| TTE or TEE performed | 27 (100) | 48 (53) | n/a | < 0.001 |
| Heart surgery, incl. CIED extraction | 13 (48) | 0 (0) | n/a | < 0.001 |
| Antibiotic treatment, days (median (IQR)) | 35 (25–46) | 12 (5–17) | n/a | < 0.001 |
| Days of hospital stay (median (IQR)) | 32 (25–39) | 10 (5–17) | n/a | < 0.001 |
| Relapse of infection | 0 | 1* | 1.4 (0.06–36) | 0.83 |
| Death within 30 days | 1 (4) | 14 (15) | 0.21 (0.03–1.7) | 0.19 |
| Death during follow-up (365 days) | 1 (4) | 18 (20) | 0.16 (0.02–1.2) | 0.07 |
The odds ratios and their confidence intervals were calculated. The χ2 test was used when applicable and otherwise the p value of Fisher’s exact test. Continuous variables were analyzed with Wilcoxon’s rank-sum test
*See description of this case in the text